Compare ARK Next Generation Internet ETF (ARKW) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Next Generation Internet ETF vs TransMedics Group Inc — how do they compare? ARK Next Generation Internet ETF trades at $150.74, while TransMedics Group Inc trades at $86.51 (market cap $3.10B). The key difference: ARK Next Generation Internet ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| ARKW | TMDX | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $182.20 | $150.42 |
52-Week Low | $114.45 | $61.99 |
Market Cap | — | $3.10B |
Enterprise Value | — | $3.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKW trades at $151.13, up 1.04% with strong technical momentum as moving averages signal bullish alignment. The ETF faces near-term headwinds from elevated AI infrastructure spending but maintains long-term growth positioning in next-generation internet technologies. Technical indicators show mixed signals with RSI suggesting potential overbought conditions while ADX confirms strong trend strength.
The ETF's outlook balances near-term capital expenditure pressures against long-term AI and technology exposure. Key risks include market skepticism toward growth stocks and concentration in volatile tech holdings. Analyst sentiment remains cautious with a Hold rating due to current market conditions despite the fund's innovative portfolio positioning.
TransMedics Group (TMDX) trades at $87.02, down 1.57% today, amid mixed signals. The stock shows a bullish technical trend with moving averages supporting upside, but oscillators like RSI indicate overbought conditions near 78. Fundamentally, the company reported record Q2 2026 revenue but missed earnings estimates, with net income margin declining to 22.69% from 31.42% in 2025. Recent news highlights an ongoing investigation into fiduciary duties by Rosen Law Firm, adding uncertainty.
The outlook remains cautiously optimistic with a consensus price target of $99.57, implying 14% upside, supported by strong analyst buy ratings (69%). However, risks include earnings volatility, margin pressure from rising costs, and legal scrutiny. Investors should weigh robust revenue growth against execution risks and elevated valuation multiples like a P/E of 23.15.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Next Generation Internet ETF
ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.
Read more on ARKW →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
